港股異動丨恆基地產一度大漲超8% 瑞銀稱獲納入指數將有被動資金追入
恆基地產(0012.HK)盤中一度漲超8%,報25.15港元,目前漲幅維持在5%左右,截至目前成交額放大至4.4億港元。瑞銀報告稱,今早EPRA(European Public Real Estate Association)公佈對FTSE EPRA Nareit Global Real Estate Index(EPRA index)季度檢討,較驚喜是恆基地產納入該指數內。報告指,截至4月底止有140.9億美元ETF資產規模(AUM)追縱EPRA Index,估計將有被動資金追入恆基地產。瑞銀續予該股“買入”評級,目標價25.7港元,摺合每股資產淨值42.9港元折讓四成。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.